Business Wire NextGen Healthcare's NextGen Share Receives Full DirectTrust Accreditation from the Electronic Healthcare Network Accreditation Commission

HORSHAM, Pa.--NextGen Healthcare Information Systems, LLC., a leading provider of healthcare information systems and connectivity solutions, along with its sister company, Mirth, LLC, a global leader in health information technology, announced today that their Health Information Services Providers (HISP) solution, NextGen® Share, has achieved full accreditation with the Direct Trusted Agent Accreditation Program (DTAAP) from DirectTrust.org and the Electronic Healthcare Network Accreditation Commission (EHNAC). NextGen Healthcare and Mirth are both wholly owned subsidiaries of Quality Systems, Inc. (NASDAQ: QSII).

Direct Trusted Agent accreditation is a voluntary accreditation program for HISPs in partnership with EHNAC that recognizes excellence in Health Information Exchanges (HIE) and transactions via the Direct protocols. It confirms compliance with industry-established standards for security and trust and with healthcare regulatory reform measures. DTAAP was developed by DirectTrust in partnership with the EHNAC, a non-profit standards development organization and accrediting body. The criteria for DTAAP include privacy, security and confidentiality; technical performance; resources; and implementation specifications; as well as a self-attestation and site review.

DirectTrust is an independent non-profit trade organization developed to build and strengthen the security and trust framework for the exchange of health data using the Direct Project protocol, a standardized messaging protocol that allows the secure exchange of key clinical data among healthcare providers and between providers and patients. The protocol enables physicians, hospitals, labs, other providers, HIEs and state health departments to send care summaries, referrals and other data online without dedicated interfaces.

EHNAC evaluated NextGen Share in the areas of privacy, security and confidentiality; technical performance; business practices; and, organizational resources as it relates to Directed exchange participants. In addition, EHNAC reviewed the organization's process of managing and transferring protected health information and determined that the organization meets or exceeds all EHNAC criteria and industry standards. Through completion of the rigorous accreditation process, NextGen Share demonstrates adherence to strict standards and participation in the comprehensive, objective evaluation of its business.

"Endorsed by the Office of the National Coordinator for Health Information Technology (ONC), the Direct Trusted Agent Accreditation Program ensures that organizations like NextGen Healthcare and Mirth establish and uphold a superior level of trust for their stakeholders," explained Dr. David C. Kibbe, chief executive officer of DirectTrust. "The need for guidance and accountability in health information exchange is undeniable, and we applaud the company’s commitment to the highest standards in privacy, security and confidentiality."

“DTAAP accreditation for NextGen Share, combined with NextGen’s and Mirth’s industry-leading interoperability products, underscores our commitment to enabling the secure exchange of clinical data on behalf of our clients,” says Gary Teichrow, co-founder and vice president, research and development at Mirth. “With NextGen Share’s free direct messaging, healthcare organizations are better equipped to meet Meaningful Use Stage 2 transitions of care objectives, and communicate with providers utilizing other DTAAP accredited HISPs with disparate EHRs. The liquidity of data through NextGen Share extends the reach of our clients and allows them to improve care coordination and better manage referrals.”

About DirectTrust and EHNAC

DirectTrust is an independent non-profit trade association created by and for participants in the Direct community, to establish and maintain a national Security and Trust framework in support of Direct exchange. EHNAC is an independent, federally recognized, standards development organization and accrediting body designed to improve transactional quality, operational efficiency, and data security in healthcare.

About Mirth

Mirth, LLC, a wholly owned subsidiary of Quality Systems, Inc., is a global leader in health information technology that helps clients achieve interoperability across silo-structured data systems. Mirth's solutions are used daily by thousands of health professionals and institutions worldwide to streamline care management processes and to securely exchange health information across enterprises, communities and broad geographies. For more information, visit www.mirth.com.

About NextGen Healthcare

NextGen Healthcare Information Systems, LLC, a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, connectivity and financial solutions, including revenue cycle management services for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen, Facebook at http://www.facebook.com/NextGenHealthcare or LinkedIn at http://www.linkedin.com/company/nextgen-healthcare-information-systems.

Certain statements in this news release are forward-looking statements within the meaning of the federal securities laws, including but not limited to those statements made by Gary Teichrow related to the Company’s future products and offerings, and developments and trends in the healthcare industry. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the Company’s expectations and projections. Factors that could cause the anticipated results to differ from those described in the forward-looking statements include the possibility that products will not achieve or sustain market acceptance; the impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in our software; changing economic, political or regulatory influences in the healthcare industry; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; and general economic conditions. Additional risks and uncertainties are set forth in the Company’s public filings with the U.S. Securities and Exchange Commission, including the discussion under the heading "Risk Factors" in the Company’s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. The Company expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.
© 2014 Quality Systems, Inc., Irvine, CA 92612
® marks owned by Quality Systems, Inc.
All other non-QSI Marks are the property of their respective owners

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.